GLP-3 RT: The Triple-Agonist Frontier in Metabolic ResearchAs we move through the second quarter of 2026, the terminology of metabolic enhancement is evolving. While the public remains focused on GLP-1 and GIP, the research community has shifted its gaze toward the "Triple G" or GLP-3 RT—the laboratory designation for Retatrutide.This isn't just